/TPIA

TPIA Stock - Mycotopia Therapies, Inc.

Q: What is the analyst price target for TPIA?

Analyst price target information is not currently available for TPIA.

Q: What is TPIA's market cap?

Market capitalization information is not currently available for TPIA.

Healthcare|Medical - Care Facilities|OTC

$0.02-5.00%

$0.00 (-5.00%) • Feb 14

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.02

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TPIA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.56

52W High$0.18

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	$-61,217	$-1,001	$-249	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-1,634,817	$-616,724	$-1,875,919	$-2,669,109	$-159,449
Net Income	$-1,848,275	$-1,181,347	$-3,626,985	$-2,972,351	$-242,205
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.14	$-0.00	$-0.25	$-0.22	$-0.02

Company Overview

Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.

Visit Website

Earnings History & Surprises

TPIA

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.02

Q3 2023

EPS Surprise History

Q4 22

No data

Q2 23

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.02	—	—
Q2 2023	Jun 30, 2023	—	$-0.02	—	—
Q4 2022	Dec 31, 2022	—	$-0.07	—	—

Frequently Asked Questions about TPIA

What is TPIA's current stock price?

Mycotopia Therapies, Inc. (TPIA) is currently trading at $0.02 per share. The stock has moved -5.00% today.

What is the analyst price target for TPIA?

No analyst price targets are currently available for this stock.

What sector is Mycotopia Therapies, Inc. in?

Mycotopia Therapies, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the OTC exchange.

What is TPIA's market cap?

Mycotopia Therapies, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does TPIA pay dividends?

No, Mycotopia Therapies, Inc. does not currently pay a dividend to shareholders.